New Cell-Free Test Rapidly Detects COVID-19 Neutralizing Antibodies
Scientists have developed a new way to quantify whether an individual has neutralizing antibodies that could prevent the SARS-CoV-2 virus from infecting cells using a method that is more broadly applicable than those currently available. More...26 Oct 2020
Gilead’s Veklury (Remdesivir) Receives Full FDA Approval as First Treatment for COVID-19
The US Food and Drug Administration has approved Gilead Sciences’ (Foster City, CA, USA) antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. More...26 Oct 2020
Portable, Non-Invasive Respiratory Monitoring System Helps Detect Presence of COVID-19 in At-Risk Elderly Population
The use of a portable, non-invasive respiratory monitoring system that detects pulmonary gas exchange impairment is proving valuable in monitoring the elderly and those who are at a high-risk of contracting respiratory illnesses like COVID-19. More...26 Oct 2020
Closed-Circuit Nebulizer Technology to Help Deliver Potential COVID-19 Inhaled Therapies
A closed-circuit nebulizer technology, which is being used in hospitals to deliver aerosolized medication to critically-ill ventilated COVID-19 patients, will help ensure safe delivery of inhaled antiviral drugs for the treatment of COVID-19. More...26 Oct 2020
Use of Genetic Sequencing to Track SARS-CoV-2 Mutations Can Improve Diagnostic Testing Accuracy and Vaccine Effectiveness
Scientists are tracking the SARS-CoV-2 virus that causes COVID-19 by sequencing the genome of virus samples collected from diagnostic testing. Using next generation sequencing on SARS-CoV-2 will help accurately diagnose the novel coronavirus, identify mutations and track its history. More...23 Oct 2020
Gold Member
Blood Gas Analyzer
i-Check200
Vessel Sealing Instrument
ERGOseal
Rapid Sepsis Test
SeptiCyte RAPID
In Other News
Future COVID-19 Tests Could Be Based on Biomarkers and Molecular Profiles of Individuals
Unique AI-Based Counting System Advances Accuracy and Throughput for COVID-19 Vaccine
New COVID-19 Mass Screening Method Could Be 20 Times Cheaper Than Individual Testing
Study Finds Corticosteroids to Be Most Effective Treatment for Cytokine Storm in COVID-19 Patients
AstraZeneca US COVID-19 Vaccine Trial to Resume Upon Completion of FDA Review
Mass Spectrometry-Based Device Uses Breath Samples to Rapidly Identify COVID-19 Strains
New Simple, Portable and Easy-To-Use Technology Diagnoses COVID-19 Infection in Just 30 Minutes
Rapid COVID-19 Antigen Tests Less Effective at Detecting SARS-CoV-2 in People with Low Virus Levels, Finds Study
Spectral CT Improves Detection of Early-Stage COVID-19
CerTest Biotec and BD Secure CE Mark for Combination COVID-19, Influenza, RSV Test on BD MAX System
Moderna’s COVID-19 Vaccine Could Be Granted FDA Emergency Use Authorization in December, Says CEO
World’s First Human Challenge COVID-19 Study to Infect Healthy Young Volunteers with SARS-CoV-2 Virus
ThermoGenesis’ Breakthrough Lateral Flow Immunoassay Test Reader to Help Track Antibody Response of COVID-19 Vaccine Recipients
Novel T Cell Targets Found in Recovering COVID-19 Patients to Enable Development of Next-Generation Vaccines
Saline Oral Rinse COVID-19 RT-PCR Test Could Be a Game-Changer for Coronavirus Testing
Breakthrough Study Identifies What Makes SARS-CoV-2 Highly Infectious and Spread Rapidly in Human Cells
New Testing Process Could Make It Faster, Easier, And Less Expensive to Measure COVID-19 Antibody Levels
New Lab Testing Procedure Specifically Identifies SARS-CoV-2 Neutralizing Antibodies
New Serology Assay Accelerates COVID-19 Research through Rapid Characterization of Immune Response to SARS-CoV-2 Antigens
Engineered COVID-19 Antibody Enables Extremely Rapid Identification of SARS-CoV-2 in Nasal Mucus, Saliva, and Blood
New Rapid Lateral Flow Antigen COVID-19 Testing Platform Processes 200-300 People Each Hour and Reports Results in 15 Minutes (C)
Novel COVID-19 Immunity Test Predicts Both Infection Risk in Healthy Individuals and Disease Severity in Patients
Pfizer to Seek FDA Emergency Use Authorization for Its COVID-19 Vaccine in Late November
